The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Exploratory phase II evaluation of cabozantinib in recurrent/metastatic uterine carcinosarcoma (CS): A study of the Princess Margaret, Chicago, and California phase II consortia.
 
Victoria Mandilaras
No Relationships to Disclose
 
Neesha C. Dhani
Honoraria - Celgene; Sanofi
Consulting or Advisory Role - Celgene; Incyte
 
Qian Tan
No Relationships to Disclose
 
Angela Jain
Consulting or Advisory Role - Castle Biosciences
Travel, Accommodations, Expenses - Castle Biosciences
 
Carolyn Johnston
No Relationships to Disclose
 
Hal W. Hirte
No Relationships to Disclose
 
Katia Sonia Tonkin
Honoraria - Eisai; Novartis/Pfizer; Roche Canada
Travel, Accommodations, Expenses - Roche Canada
 
Mihaela C. Cristea
Honoraria - Boehringer Ingelheim
Consulting or Advisory Role - Boehringer Ingelheim
Research Funding - Trovagene
 
Koji Matsuo
No Relationships to Disclose
 
Marcus O. Butler
Honoraria - Bristol-Myers Squibb; Merck; Novartis; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; Immunovaccine; Merck; Novartis
Expert Testimony - Merck
 
Stephanie Lheureux
Consulting or Advisory Role - AstraZeneca; AstraZeneca
 
Julia V. Burnier
No Relationships to Disclose
 
Lisa Wang
No Relationships to Disclose
 
Anjali Mehta
No Relationships to Disclose
 
John Joseph Wright
No Relationships to Disclose
 
Amit M. Oza
Honoraria - WebRx
Consulting or Advisory Role - Amgen; Clovis Oncology; Immunovaccine; Verastem
Research Funding - AstraZeneca (Inst); AstraZeneca (Inst); Merck (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca